This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen de acción MDC
Medlab Clinical Limited, a biotechnology company, researches, develops, and pre-commercializes pharmaceutical and nutraceutical products in Australia.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
+ 1 riesgos adicionales
Competidores de Medlab Clinical Limited
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | AU$6.60 |
| 52 Week High | AU$14.94 |
| 52 Week Low | AU$6.45 |
| Beta | 1.1 |
| 1 Month Change | 0% |
| 3 Month Change | -4.21% |
| 1 Year Change | -43.59% |
| 3 Year Change | -79.05% |
| 5 Year Change | -91.85% |
| Change since IPO | -78.00% |
Noticias y actualizaciones recientes
Recent updates
Shareholders May Be More Conservative With Medlab Clinical Limited's (ASX:MDC) CEO Compensation For Now
Oct 06
Is Medlab Clinical (ASX:MDC) In A Good Position To Invest In Growth?
Oct 05What We Learned About Medlab Clinical's (ASX:MDC) CEO Pay
Feb 21Medlab Clinical (ASX:MDC) Share Prices Have Dropped 69% In The Last Three Years
Dec 30
Medlab Clinical Limited (ASX:MDC) Is Expected To Breakeven In The Near Future
Nov 22Rentabilidad de los accionistas
| MDC | AU Biotechs | Mercado AU | |
|---|---|---|---|
| 7D | 0% | 2.9% | 0.4% |
| 1Y | -43.6% | -7.5% | 6.0% |
Rentabilidad vs. Industria: MDC underperformed the Australian Biotechs industry which returned 11.4% over the past year.
Rentabilidad vs. Mercado: MDC underperformed the Australian Market which returned -1.5% over the past year.
Volatilidad de los precios
| MDC volatility | |
|---|---|
| MDC Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 11.3% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in AU Market | 17.6% |
| 10% least volatile stocks in AU Market | 3.5% |
Precio estable de las acciones: MDC has not had significant price volatility in the past 3 months.
Volatilidad a lo largo del tiempo: Insufficient data to determine MDC's volatility change over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2012 | n/a | Sean Hall | www.medlab.co |
Resumen de fundamentos de Medlab Clinical Limited
| Estadísticas fundamentales de MDC | |
|---|---|
| Capitalización bursátil | AU$15.07m |
| Beneficios(TTM) | -AU$8.32m |
| Ingresos (TTM) | AU$1.54m |
9.8x
Ratio precio-ventas (PS)-1.8x
Ratio precio-beneficio (PE)¿Está MDC sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de MDC | |
|---|---|
| Ingresos | AU$1.54m |
| Coste de los ingresos | AU$336.29k |
| Beneficio bruto | AU$1.20m |
| Otros gastos | AU$9.52m |
| Beneficios | -AU$8.32m |
Últimos beneficios comunicados
Jun 30, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -3.64 |
| Margen bruto | 78.11% |
| Margen de beneficio neto | -541.67% |
| Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado MDC a largo plazo?
Ver rendimiento histórico y comparativa